Literature DB >> 28135360

Retinal Architecture and Melanopsin-Mediated Pupillary Response Characteristics: A Putative Pathophysiologic Signature for the Retino-Hypothalamic Tract in Multiple Sclerosis.

Ethan Meltzer1, Peter V Sguigna1, Adnan Subei2, Shin Beh1, Eric Kildebeck3, Darrel Conger1, Amy Conger1, Marlen Lucero4, Benjamin S Frohman4, Ashley N Frohman4, Shiv Saidha5, Steven Galetta6, Peter A Calabresi5, Robert Rennaker7, Teresa C Frohman1, Randy H Kardon8, Laura J Balcer9, Elliot M Frohman10.   

Abstract

Importance: A neurophysiologic signature of the melanopsin-mediated persistent constriction phase of the pupillary light reflex may represent a surrogate biomarker for the integrity of the retinohypothalamic tract, with potential utility for investigating alterations in homeostatic mechanisms associated with brain disorders and implications for identifying new treatments. Objective: To characterize abnormalities of retinal architecture in patients with multiple sclerosis (MS) and corresponding alterations in the melanopsin-mediated sustained pupillary constriction response. Design, Setting, and Participants: The case-control study was an experimental assessment of various stimulus-induced pupillary response characteristics and was conducted at a university clinical center for MS from September 6, 2012, to February 2015. Twenty-four patients with MS (48 eyes) and 15 individuals serving as controls (30 eyes) participated. The melanopsin-mediated, sustained pupillary constriction phase response following cessation of a blue light stimulus was compared with the photoreceptor-mediated pupillary constriction phase response following cessation of a red light stimulus. Optical coherence tomography was used to characterize the association between pupillary response characteristics and alterations in retinal architecture, specifically, the thickness of the retinal ganglion cell layer and inner plexiform layer (GCL + IPL). Main Outcomes and Measures: Association of pupillary response characteristics with alterations in retinal architecture.
Results: Of 24 patients with MS included in the analysis, 17 were women (71%); mean (SD) age was 47 (11) years. Compared with eyes from individuals with MS who had normal optical coherence tomography-derived measures of retinal GCL + IPL thickness, eyes of patients who had GCL + IPL thickness reductions to less than the first percentile exhibited a correspondingly significant attenuation of the melanopsin-mediated sustained pupillary response (mean [SD] pupillary diameter ratios at a point in time, 0.18 [0.1] vs 0.33 [0.09]; P < .001, generalized estimating equation models accounting for age and within-patient intereye correlations). Conclusions and Relevance: In this case-control study, attenuation of the melanopsin-mediated sustained pupillary constriction response was significantly associated with thinning of the GCL + IPL sector of the retina in the eyes of patients with MS, particularly those with a history of acute optic neuritis. Melanopsin-containing ganglion cells in the retina represent, at least in part, the composition of the retinohypothalamic tract. As such, our findings may signify the ability to elucidate a putative surrogate neurophysiologic signature that correlates with a constellation of homeostatic mechanisms in both health and illness.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28135360      PMCID: PMC5822208          DOI: 10.1001/jamaneurol.2016.5131

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  41 in total

Review 1.  Hypothalamic regulation of sleep and circadian rhythms.

Authors:  Clifford B Saper; Thomas E Scammell; Jun Lu
Journal:  Nature       Date:  2005-10-27       Impact factor: 49.962

Review 2.  Multiple sclerosis--the plaque and its pathogenesis.

Authors:  Elliot M Frohman; Michael K Racke; Cedric S Raine
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

3.  Retinal architecture predicts pupillary reflex metrics in MS.

Authors:  A R Salter; A Conger; T C Frohman; R Zivadinov; E Eggenberger; P Calabresi; G Cutter; L Balcer; E M Frohman
Journal:  Mult Scler       Date:  2008-12-17       Impact factor: 6.312

4.  Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN.

Authors:  Dennis M Dacey; Hsi-Wen Liao; Beth B Peterson; Farrel R Robinson; Vivianne C Smith; Joel Pokorny; King-Wai Yau; Paul D Gamlin
Journal:  Nature       Date:  2005-02-17       Impact factor: 49.962

5.  TH17 cell differentiation is regulated by the circadian clock.

Authors:  Xiaofei Yu; Darcy Rollins; Kelly A Ruhn; Jeremy J Stubblefield; Carla B Green; Masaki Kashiwada; Paul B Rothman; Joseph S Takahashi; Lora V Hooper
Journal:  Science       Date:  2013-11-08       Impact factor: 47.728

6.  Multiple sclerosis: can retinal imaging accurately detect optic neuritis?

Authors:  Elliot M Frohman; Laura J Balcer; Peter A Calabresi
Journal:  Nat Rev Neurol       Date:  2010-03       Impact factor: 42.937

7.  The neuro-ophthalmology of multiple sclerosis.

Authors:  Teresa C Frohman; Jennifer Graves; Laura J Balcer; Steven L Galetta; Elliot M Frohman
Journal:  Continuum (Minneap Minn)       Date:  2010-10

8.  Intrinsically photosensitive retinal ganglion cell activity is associated with decreased sleep quality in patients with glaucoma.

Authors:  Carolina P B Gracitelli; Gloria Liliana Duque-Chica; Marina Roizenblatt; Ana Laura de Araújo Moura; Balazs V Nagy; Geraldine Ragot de Melo; Paula Delegrego Borba; Sérgio H Teixeira; Sergio Tufik; Dora Fix Ventura; Augusto Paranhos
Journal:  Ophthalmology       Date:  2015-04-07       Impact factor: 12.079

Review 9.  Crosstalk between the circadian clock circuitry and the immune system.

Authors:  Nicolas Cermakian; Tanja Lange; Diego Golombek; Dipak Sarkar; Atsuhito Nakao; Shigenobu Shibata; Gianluigi Mazzoccoli
Journal:  Chronobiol Int       Date:  2013-05-22       Impact factor: 2.877

10.  The circadian response of intrinsically photosensitive retinal ganglion cells.

Authors:  Andrew J Zele; Beatrix Feigl; Simon S Smith; Emma L Markwell
Journal:  PLoS One       Date:  2011-03-14       Impact factor: 3.240

View more
  7 in total

Review 1.  Optical coherence tomography in multiple sclerosis.

Authors:  Josefine Britze; Jette Lautrup Frederiksen
Journal:  Eye (Lond)       Date:  2018-02-02       Impact factor: 3.775

2.  Melanopsin-Mediated Acute Light Responses Measured in Winter and in Summer: Seasonal Variations in Adults with and without Cataracts.

Authors:  Mirjam Münch; Myriam Ladaique; Ségolène Roemer; Kattayoon Hashemi; Aki Kawasaki
Journal:  Front Neurol       Date:  2017-09-11       Impact factor: 4.003

Review 3.  Standards in Pupillography.

Authors:  Carina Kelbsch; Torsten Strasser; Yanjun Chen; Beatrix Feigl; Paul D Gamlin; Randy Kardon; Tobias Peters; Kathryn A Roecklein; Stuart R Steinhauer; Elemer Szabadi; Andrew J Zele; Helmut Wilhelm; Barbara J Wilhelm
Journal:  Front Neurol       Date:  2019-02-22       Impact factor: 4.003

4.  The Efemp1R345W Macular Dystrophy Mutation Causes Amplified Circadian and Photophobic Responses to Light in Mice.

Authors:  Stewart Thompson; Frederick R Blodi; Demelza R Larson; Michael G Anderson; Steven F Stasheff
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-05-01       Impact factor: 4.799

Review 5.  Intrinsically Photosensitive Retinal Ganglion Cells of the Human Retina.

Authors:  Ludovic S Mure
Journal:  Front Neurol       Date:  2021-03-25       Impact factor: 4.003

Review 6.  Optical Coherence Tomography and Optical Coherence Tomography with Angiography in Multiple Sclerosis.

Authors:  Ioannis-Nikolaos Chalkias; Christos Bakirtzis; Demetrios Pirounides; Marina Kleopatra Boziki; Nikolaos Grigoriadis
Journal:  Healthcare (Basel)       Date:  2022-07-25

7.  Pulses of Melanopsin-Directed Contrast Produce Highly Reproducible Pupil Responses That Are Insensitive to a Change in Background Radiance.

Authors:  Harrison McAdams; Aleksandra Igdalova; Manuel Spitschan; David H Brainard; Geoffrey K Aguirre
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-11-01       Impact factor: 4.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.